Zou Z - Search Results

1

[Research progress on ferroptosis regulation in tumor immunity of hepatocellular carcinoma].

Mo Y, Zou Z, Chen E. Mo Y, et al. Among authors: zou z. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Dec 25;53(6):715-725. doi: 10.3724/zdxbyxb-2024-0117. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39694527 Review. Chinese.

2

Targeting ferroptosis in hepatocellular carcinoma.

Mo Y, Zou Z, Chen E. Mo Y, et al. Among authors: zou z. Hepatol Int. 2024 Feb;18(1):32-49. doi: 10.1007/s12072-023-10593-y. Epub 2023 Oct 26. Hepatol Int. 2024. PMID: 37880567 Review.

3

Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer.

Chen E, Yi J, Jiang J, Zou Z, Mo Y, Ren Q, Lin Z, Lu Y, Zhang J, Liu J. Chen E, et al. Among authors: zou z. BMC Cancer. 2022 Oct 4;22(1):1037. doi: 10.1186/s12885-022-10122-4. BMC Cancer. 2022. PMID: 36195833 Free PMC article.

4

A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy.

Chen E, Mo Y, Yi J, Liu J, Luo T, Li Z, Lin Z, Hu Y, Zou Z, Liu J. Chen E, et al. Among authors: zou z. Aging (Albany NY). 2023 Aug 16;15(16):7933-7955. doi: 10.18632/aging.204862. Epub 2023 Aug 16. Aging (Albany NY). 2023. PMID: 37589508 Free PMC article.

5

Correction to: Targeting ferroptosis in hepatocellular carcinoma.

Mo Y, Zou Z, Chen E. Mo Y, et al. Among authors: zou z. Hepatol Int. 2024 Jun;18(3):1065. doi: 10.1007/s12072-023-10623-9. Hepatol Int. 2024. PMID: 38129721 No abstract available.

6

Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.

Chen E, Zou Z, Wang R, Liu J, Peng Z, Gan Z, Lin Z, Liu J. Chen E, et al. Among authors: zou z. Front Immunol. 2024 Apr 17;15:1244392. doi: 10.3389/fimmu.2024.1244392. eCollection 2024. Front Immunol. 2024. PMID: 38694506 Free PMC article.

7

CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway.

Chen E, He Y, Jiang J, Yi J, Zou Z, Song Q, Ren Q, Lin Z, Lu Y, Liu J, Zhang J. Chen E, et al. Among authors: zou z. Exp Hematol Oncol. 2023 Jan 13;12(1):9. doi: 10.1186/s40164-022-00366-y. Exp Hematol Oncol. 2023. PMID: 36639822 Free PMC article.

8

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges.

Zou Z, Tao T, Li H, Zhu X. Zou Z, et al. Cell Biosci. 2020 Mar 10;10:31. doi: 10.1186/s13578-020-00396-1. eCollection 2020. Cell Biosci. 2020. PMID: 32175074 Free PMC article. Review.

9

The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.

Zou Z, Zhou S, Liang G, Tang Z, Li K, Tan S, Zhang X, Zhu X. Zou Z, et al. Mol Omics. 2021 Jun 14;17(3):438-453. doi: 10.1039/d0mo00113a. Mol Omics. 2021. PMID: 34110327

10

Cytotoxicity in vitro, cellular uptake, localization and apoptotic mechanism studies induced by ruthenium(II) complex.

Chen J, Zhang Y, Li G, Peng F, Jie X, She J, Dongye G, Zou Z, Rong S, Chen L. Chen J, et al. Among authors: zou z. J Biol Inorg Chem. 2018 Mar;23(2):261-275. doi: 10.1007/s00775-017-1528-2. Epub 2017 Dec 19. J Biol Inorg Chem. 2018. PMID: 29260327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,665 results

Search Page

Filters